medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/1607-0763-2019-2-7-26medvis-766Research ArticleОТ ПРИГЛАШЕННОГО РЕДАКТОРАFROM THE INVITED EDITORСовременный взгляд на принципы диагностики и лечения рака прямой кишки по данным МРТ (обзор литературы)Contemporary view to the principles of rectal cancer diagnostics and treatment according to MRI (literature review)ГришкоП. Ю.GrishkoP. Yu.

Гришко Павел Юрьевич – врач-рентгенолог отделения лучевой диагностики

197758, п. Песочный, Ленинградская область, Ленинградская ул., д. 68

Тел.: +7-921-595-05-63

Pavel Yu. Grishko – radiologist at the Department of Radiology 

197758 Russian Federation, St. Petersburg, Pesochny, Leningradskaya str., 68.

Phone: 7-921-595-05-63

dr.grishko@mail.ruБалясниковаС. С.BalyasnikovaS. S.

Балясникова Светлана Сергеевна – канд. мед. наук, старший научный сотрудник научного отделения диагностической и интервенционной радиологии

Radiologist at the Department of Radiology 

Svetlana S. Balyasnikova – cand. of med. sci., radiologist at the Department of Radiology 

Radiologist at the Department of Radiology 

СамсоновД. В.SamsonovD. V.

Denis V. Samsonov – cand. of med. sci., oncologist at the Department of Abdominal Oncology

МищенкоА. В.MishchenkoA. V.

Мищенко Андрей Владимирович – доктор мед. наук, заведующий научным отделением диагностической и интервенционной радиологии

профессор НК и ОЦ “Лучевая диагностика и ядерная медицина” 

Andrei V. Mishchenko – doct. of med. sci., Head of the Department of Diagnostic and Interventional radiology 

Professor of the Scientific Clinical and Educational Center “Radiation Diagnostics and Nuclear Medicine”

КарачунА. М.KarachunA. M.

Карачун Алексей Михайлович – доктор мед. наук, заведующий хирургическим отделением абдоминальной онкологии, ведущий научный сотрудник научного отделения опухолей желудочно-кишечного тракта

Alexey M. Karachun – doct. of med. sci., Head of the Department of abdominal oncology, Leading researcher of the Department of Gastrointestinal Tumors

ПравосудовИ. В.PravosudovI. V.

Правосудов Игорь Витальевич – доктор мед. наук, профессор, ведущий научный сотрудник научного отделения опухолей желудочнокишечного тракта

профессор кафедры онкологии медицинского факультета 

Igor V. Pravosudov – doct. of med. sci., Professor, Leading researcher of the Department of Gastrointestinal Tumors

НМИЦ онкологии имени Н.Н. ПетроваРоссияNational Medical Research Center of Oncology named after N. N. PetrovRussian FederationНМИЦ онкологии имени Н.Н. Петрова; The Royal Marsden Hospital, NHS Foundation Trust, Downs Road; Imperial College LondonРоссияNational Medical Research Center of Oncology named after N. N. Petrov; The Royal Marsden Hospital, NHS Foundation Trust, Downs Road; Imperial College LondonRussian Federation20191607201902726Copyright © Гришко П.Ю., Балясникова С.С., Самсонов Д.В., Мищенко А.В., Карачун А.М., Правосудов И.В., 20192019Гришко П.Ю., Балясникова С.С., Самсонов Д.В., Мищенко А.В., Карачун А.М., Правосудов И.В.Grishko P.Y., Balyasnikova S.S., Samsonov D.V., Mishchenko A.V., Karachun A.M., Pravosudov I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/766

В статье рассматриваются последние достижения лучевой диагностики при обследовании пациентов с предполагаемым и верифицированным раком прямой кишки на различных этапах лечебно-диагностического процесса. Показана высокая роль качественной визуализации в диагностике рака прямой кишки, подробно описываются возможности магнитно-резонансной томографии в первичной диагностике заболевания и при рестадировании опухоли после проведения неоадъювантного лечения, обсуждаются оптимальная методика проведения исследования и принципы интерпретации полученных данных в ежедневной практике.

In this article are reviewed the most recent diagnostic methods for patients with probable and verified rectal cancer, in different stages of treatment. The importance of high quality visualization of rectal cancer, opportunities of magnetic resonance imaging in primary diagnosis and restaging of the disease after neoadjuvant chemotherapy, optimal examination methods and interpretation of images in routine are discussed.

рак прямой кишкидиагностикаоценка распространенностинеоадъювантное лечениемагнитно-резонансная томографияrectal cancerdiagnosticsdisease extent assessmentneoadjuvant chemotherapymagnetic resonance imagingReferencesGlynne-Jones R., Wyrwicz L., Tiret E., Brown G., Rodel C., Cervantes A., Arnold D., ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl. 4): 22–40. http://doi.org/10.1093/annonc/mdx224.Glynne-Jones R., Wyrwicz L., Tiret E., Brown G., Rodel C., Cervantes A., Arnold D., ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl. 4): 22–40. http://doi.org/10.1093/annonc/mdx224.American Cancer Society. Cancer Facts & Figures. 2017. Available at: https://www.cancer.org/content/dam/ cancer-org/research/cancer-facts-and-statistics/ annual-cancer-facts-and-figures/2017/cancer-factsand-figures-2017.pdf (accessed August 12, 2018).American Cancer Society. Cancer Facts & Figures. 2017. Available at: https://www.cancer.org/content/dam/ cancer-org/research/cancer-facts-and-statistics/ annual-cancer-facts-and-figures/2017/cancer-factsand-figures-2017.pdf (accessed August 12, 2018). (In Russian)Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2011; 22 (3, Прил. 1) (85): 1–170.Davydov M.I., Aksel E.M. Cancer statistics in Russia and CIS in 2009. Journal of N.N. Blokhin Russian Cancer Research Center RAMS. 2011; 22 (3, Suppl. 1) (85): 1–170. (In Russian)Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.Kaprin A.D., Starinskii V.V., Petrova G.V. The state of oncological care for the population of Russia in 2017. M.: MNIOI im. P.A. Gertzena – filial FGBU “NMITZ radiologii” Minzdrava Rossii, 2018. 250 p. (In Russian)Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.Kaprin A.D., Starinskii V.V., Petrova G.V. Malignant neoplasms in Russia in 2016 (morbidity and mortality). M.: MNIOI im. P.A. Gertzena – filial FGBU “NMITZ radiologii” Minzdrava Rossii, 2018. 250 p. (In Russian)Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc. Royal Soc. Med. 1974; 67 (6): 451–457.Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc. Royal Soc. Med. 1974; 67 (6): 451–457.Kang H., O'Connell J.B., Leonardi M.J., Maggard M.A., McGory M.L., Ko C.Y. Rare tumors of the colon and rectum: a national review. Int. J. Colorectal Dis. 2007; 22 (2): 183–189.Kang H., O'Connell J.B., Leonardi M.J., Maggard M.A., McGory M.L., Ko C.Y. Rare tumors of the colon and rectum: a national review. Int. J. Colorectal Dis. 2007; 22 (2): 183–189.Union for International Cancer Control (UICC). Available at: https://www.hoofdhalskanker.info/wpavl/wp-content/ uploads/TNM-Classification-of-Malignant-Tumours-8thedition.pdf. (accessed August 12, 2018).Union for International Cancer Control (UICC). Available at: https://www.hoofdhalskanker.info/wpavl/wp-content/ uploads/TNM-Classification-of-Malignant-Tumours-8thedition.pdf. (accessed August 12, 2018). (In Russian)Balyasnikova S., Brown G. Imaging Advances in Colorectal Cancer. Curr. Colorectal Cancer Rep. 2016; 12 (3): 162–169. http://doi.org/10.1007/s11888-016-0321-x.Balyasnikova S., Brown G. Imaging Advances in Colorectal Cancer. Curr. Colorectal Cancer Rep. 2016; 12 (3): 162–169. http://doi.org/10.1007/s11888-016-0321-x.Beets-Tan R.G.H., Lambregts D.M.J., Maas M., Bipat S., Barbaro B., Curvo-Semedo L., Fenlon H.M., Gollub M.J., Gourtsoyianni S., Halligan S., Hoeffel C., Kim S.H., Laghi A., Maier A., Rafaelsen S.R., Stoker J., Taylor S.A., Torkzad M.R., Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastro intestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 2018; 28 (4): 1465–1475. http://doi.org/10.1007/s00330-017-5026-2.Beets-Tan R.G.H., Lambregts D.M.J., Maas M., Bipat S., Barbaro B., Curvo-Semedo L., Fenlon H.M., Gollub M.J., Gourtsoyianni S., Halligan S., Hoeffel C., Kim S.H., Laghi A., Maier A., Rafaelsen S.R., Stoker J., Taylor S.A., Torkzad M.R., Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastro intestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 2018; 28 (4): 1465–1475. http://doi.org/10.1007/s00330-017-5026-2.Peschaud F., Benoist S., Julie C., Penna C., Nordlinger B. The mesorectum: an anatomical entity that is difficult to evaluate with MRI. Morphologie: bulletin de l'Association des anatomistes. 2005; 89 (286): 126–130.Peschaud F., Benoist S., Julie C., Penna C., Nordlinger B. The mesorectum: an anatomical entity that is difficult to evaluate with MRI. Morphologie: bulletin de l'Association des anatomistes. 2005; 89 (286): 126–130.Rodel C., Sauer R., Fietkau R. The Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer. Strahlentherapie Onkol. 2009; 185 (8): 488–492. http://doi.org/10.1007/s00066-009-2043-3.Rodel C., Sauer R., Fietkau R. The Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer. Strahlentherapie Onkol. 2009; 185 (8): 488–492. http://doi.org/10.1007/s00066-009-2043-3.Al-Sukhni E., Milot L., Fruitman M., Beyene J., Victor J.C., Schmocker S., Brown G., McLeod R., Kennedy E. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Ann. Surg. Oncol. 2012; 19 (7): 2212–2223. http://doi.org/10.1245/s10434-011-2210-5.Al-Sukhni E., Milot L., Fruitman M., Beyene J., Victor J.C., Schmocker S., Brown G., McLeod R., Kennedy E. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Ann. Surg. Oncol. 2012; 19 (7): 2212–2223. http://doi.org/10.1245/s10434-011-2210-5.Karatag O., Karatag G.Y., Ozkurt H., Degirmenci H.K., Avlanmis O., Basak M., Baykan A. The ability of phasedarray MRI in preoperative staging of primary rectal cancer: correlation with histopathological results. Diagn. Interv. Radiol. 2012; 18 (1): 20–26. http://doi.org/10.4261/1305-3825.DIR.3394-10.2.Karatag O., Karatag G.Y., Ozkurt H., Degirmenci H.K., Avlanmis O., Basak M., Baykan A. The ability of phasedarray MRI in preoperative staging of primary rectal cancer: correlation with histopathological results. Diagn. Interv. Radiol. 2012; 18 (1): 20–26. http://doi.org/10.4261/1305-3825.DIR.3394-10.2.Kim S.H., Lee J.M., Park H.S., Eun H.W., Han J.K., Choi B.I. Accuracy of MRI for Predicting the Circumferential Resection Margin, Mesorectal Fascia Invasion, and Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. J. Magn. Reson. Imaging. 2009; 29 (5): 1093–1101. http://doi.org/10.1002/jmri.21742.Kim S.H., Lee J.M., Park H.S., Eun H.W., Han J.K., Choi B.I. Accuracy of MRI for Predicting the Circumferential Resection Margin, Mesorectal Fascia Invasion, and Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. J. Magn. Reson. Imaging. 2009; 29 (5): 1093–1101. http://doi.org/10.1002/jmri.21742.Koh D.M., Brown G., Temple L., Blake H., Raja A., Toomey P., Bett N., Farhat S., Norman A.R., Daniels I., Husband J.E. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur. Radiol. 2005; 15 (8): 1650–1657. http://doi.org/10.1007/s00330-005-2751-8.Koh D.M., Brown G., Temple L., Blake H., Raja A., Toomey P., Bett N., Farhat S., Norman A.R., Daniels I., Husband J.E. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur. Radiol. 2005; 15 (8): 1650–1657. http://doi.org/10.1007/s00330-005-2751-8.Nougaret S., Reinhold C., Mikhael H.W., Rouanet P., Bibeau F., Brown G. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”? Radiology. 2013; 268 (2): 329–343. http://doi.org/10.1148/radiol.13121361.Nougaret S., Reinhold C., Mikhael H.W., Rouanet P., Bibeau F., Brown G. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”? Radiology. 2013; 268 (2): 329–343. http://doi.org/10.1148/radiol.13121361.Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. J. Clin. Oncol. 2011; 29 (28): 3753–3760. http://doi.org/10.1200/JCO.2011.34.9068.Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. J. Clin. Oncol. 2011; 29 (28): 3753–3760. http://doi.org/10.1200/JCO.2011.34.9068.Piippo U., Paakko E., Makinen M., Makela J. Local staging of rectal cancer using the black lumen magnetic resonance imaging technique. Scand. J. Surg. 2008; 97 (3): 237–242. http://doi.org/10.1177/145749690809700306.Piippo U., Paakko E., Makinen M., Makela J. Local staging of rectal cancer using the black lumen magnetic resonance imaging technique. Scand. J. Surg. 2008; 97 (3): 237–242. http://doi.org/10.1177/145749690809700306.Mulla M., Deb R., Singh R. MRI in T staging of rectal cancer: How effective is it? Indian J. Radiol. Imaging. 2010; 20 (2): 118–121. http://doi.org/10.4103/0971-3026.63055.Mulla M., Deb R., Singh R. MRI in T staging of rectal cancer: How effective is it? Indian J. Radiol. Imaging. 2010; 20 (2): 118–121. http://doi.org/10.4103/0971-3026.63055.Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., Kessels A.G.H., Lemaire E., van Engelshoven J.M.A., Beets-Tan R.G.H. Rectal cancer: MR Imaging in local staging – Is gadolinium-based contrast material helpful? Radiology. 2005; 234 (1): 179–188. http://doi.org/10.1148/radiol.2341031403.Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., Kessels A.G.H., Lemaire E., van Engelshoven J.M.A., Beets-Tan R.G.H. Rectal cancer: MR Imaging in local staging – Is gadolinium-based contrast material helpful? Radiology. 2005; 234 (1): 179–188. http://doi.org/10.1148/radiol.2341031403.Jao S.Y., Yang B.Y., Weng H.H., Yeh C.H., Lee L.W. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis. 2010; 12 (11): 1139–1148. http://doi.org/10.1111/j.1463-1318.2009.01959.x.Jao S.Y., Yang B.Y., Weng H.H., Yeh C.H., Lee L.W. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis. 2010; 12 (11): 1139–1148. http://doi.org/10.1111/j.1463-1318.2009.01959.x.Lambregts D.M.J., Vandecaveye V., Barbaro B., Bakers F.C.H., Lambrecht M., Maas M., Hauster mans K., Valentini V., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann. Surg. Oncol. 2011; 18 (8): 2224–2231. http://doi.org/10.1245/s10434-011-1607-5.Lambregts D.M.J., Vandecaveye V., Barbaro B., Bakers F.C.H., Lambrecht M., Maas M., Hauster mans K., Valentini V., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann. Surg. Oncol. 2011; 18 (8): 2224–2231. http://doi.org/10.1245/s10434-011-1607-5.Foti P.V., Privitera G., Piana S., Palmucci S., Spatola C., Bevilacqua R., Raffaele L., Salamone V., Caltabiano R., Magro G., Destri G.L., Milone P., Ettorre G.C. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemoradiotherapy. Eur. J. Radiol. Open. 2016; 3: 145–152. http://doi.org/10.1016/j.ejro.2016.06.003.Foti P.V., Privitera G., Piana S., Palmucci S., Spatola C., Bevilacqua R., Raffaele L., Salamone V., Caltabiano R., Magro G., Destri G.L., Milone P., Ettorre G.C. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemoradiotherapy. Eur. J. Radiol. Open. 2016; 3: 145–152. http://doi.org/10.1016/j.ejro.2016.06.003.Brown G. Thin section MRI in multidisciplinary preoperative decision making for patients with rectal cancer. Br. J. Radiol. 2005; 78: 117–127. http://doi.org/10.1259/bjr/15128198.Brown G. Thin section MRI in multidisciplinary preoperative decision making for patients with rectal cancer. Br. J. Radiol. 2005; 78: 117–127. http://doi.org/10.1259/bjr/15128198.Dukes C.E. The classification of cancer of the rectum. The Journal of Pathology and Bacteriology. 1932; 35 (3): 323–332.Dukes C.E. The classification of cancer of the rectum. The Journal of Pathology and Bacteriology. 1932; 35 (3): 323–332.Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging. 2008; 8 (A): 43–45. http://doi.org/10.1102/1470-7330.2008.9008.Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging. 2008; 8 (A): 43–45. http://doi.org/10.1102/1470-7330.2008.9008.Kikuchi R., Takano M., Takagi K., Fujimoto N., Nozaki R., Fujiyoshi T., Uchida Y. Management of early invasive colorectal-cancer – risk of recurrence and clinical guidelines. Dis. Colon. Rectum. 1995; 38 (12): 1286–1295.Kikuchi R., Takano M., Takagi K., Fujimoto N., Nozaki R., Fujiyoshi T., Uchida Y. Management of early invasive colorectal-cancer – risk of recurrence and clinical guidelines. Dis. Colon. Rectum. 1995; 38 (12): 1286–1295.Puli S.R., Bechtold M.L., Reddy J.B.K., Choudhary A., Antillon M.R. Can Endoscopic Ultrasound Predict Early Rectal Cancers That Can Be Resected Endoscopically? A Meta-Analysis and Systematic Review. Dig. Dis. Sci. 2010; 55 (5): 1221–1229. http://doi.org/10.1007/s10620-009-0862-9.Puli S.R., Bechtold M.L., Reddy J.B.K., Choudhary A., Antillon M.R. Can Endoscopic Ultrasound Predict Early Rectal Cancers That Can Be Resected Endoscopically? A Meta-Analysis and Systematic Review. Dig. Dis. Sci. 2010; 55 (5): 1221–1229. http://doi.org/10.1007/s10620-009-0862-9.Balyasnikova S., Read J., Wotherspoon A., Rasheed S., Tekkis P., Tait D., Cunningham D., Brown G. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ Open Gastroenterol. 2017; 4 (1): e000151. http://doi.org/10.1136/bmjgast-2017-000151.Balyasnikova S., Read J., Wotherspoon A., Rasheed S., Tekkis P., Tait D., Cunningham D., Brown G. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ Open Gastroenterol. 2017; 4 (1): e000151. http://doi.org/10.1136/bmjgast-2017-000151.Brown G., Daniels I.R., Heald R.J., Quirke P., Blomqvist L., Sebag-Montefiore D., Moran B.J., Holm T., Strassbourg J., Peppercorn P.D., Fisher S.E., Mason B., Grp M.S. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br. Med. J. 2006; 333 (7572): 779–782. http://doi.org/10.1136/bmj.38937.646400.55.Brown G., Daniels I.R., Heald R.J., Quirke P., Blomqvist L., Sebag-Montefiore D., Moran B.J., Holm T., Strassbourg J., Peppercorn P.D., Fisher S.E., Mason B., Grp M.S. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br. Med. J. 2006; 333 (7572): 779–782. http://doi.org/10.1136/bmj.38937.646400.55.Kaur H., Choi H., You Y.N., Rauch G.M., Jensen C.T., Hou P., Chang G.J., Skibber J.M., Ernst R.D. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012; 32 (2): 389–409. http://doi.org/10.1148/rg.322115122Kaur H., Choi H., You Y.N., Rauch G.M., Jensen C.T., Hou P., Chang G.J., Skibber J.M., Ernst R.D. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012; 32 (2): 389–409. http://doi.org/10.1148/rg.322115122Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone a prospective, multicenter, european study. Ann. Surg. 2011; 253 (4): 711–719. http://doi.org/10.1097/SLA.0b013e31820b8d52.Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone a prospective, multicenter, european study. Ann. Surg. 2011; 253 (4): 711–719. http://doi.org/10.1097/SLA.0b013e31820b8d52.Benson A.B. 3rd, Venook A.P., Al-Hawary M.M., Cederquist L., Chen Y.-J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Engstrom P.F., Grem J.L., Grothey A., Hochster H.S., Hoffe S., Hunt S., Kamel A., Kirilcuk N., Krishnamurthi S., Messersmith W.A., Meyerhardt J., Mulcahy M.F., Murphy J.D., Nurkin S., Saltz L., Sharma S., Shibata D., Skibber J.M., Sofocleous C.T., Stoffel E.M., Stotsky-Himelfarb E., Willett C.G., Wuthrick E., Gregory K.M., Gurski L., Freedman-Cass D.A. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. (JNCCN). 2018; 16 (7): 874–901. http://doi.org/10.6004/jnccn.2018.0061.Benson A.B. 3rd, Venook A.P., Al-Hawary M.M., Cederquist L., Chen Y.-J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Engstrom P.F., Grem J.L., Grothey A., Hochster H.S., Hoffe S., Hunt S., Kamel A., Kirilcuk N., Krishnamurthi S., Messersmith W.A., Meyerhardt J., Mulcahy M.F., Murphy J.D., Nurkin S., Saltz L., Sharma S., Shibata D., Skibber J.M., Sofocleous C.T., Stoffel E.M., Stotsky-Himelfarb E., Willett C.G., Wuthrick E., Gregory K.M., Gurski L., Freedman-Cass D.A. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. (JNCCN). 2018; 16 (7): 874–901. http://doi.org/10.6004/jnccn.2018.0061.Al-Sukhni E., Milot L., Fruitman M., Brown G., Schmocker S., Kennedy E. User’s Guide for the Synoptic MRI Report for Rectal Cancer. Cancer Care Ontario. Canadian Cancer Society. Available at: http://www.osumcradiology. org/resources/High-Yield-Rad-info/Rectal-MRI.pdf (accessed August 12, 2018). (In Russian).Al-Sukhni E., Milot L., Fruitman M., Brown G., Schmocker S., Kennedy E. User’s Guide for the Synoptic MRI Report for Rectal Cancer. Cancer Care Ontario. Canadian Cancer Society. Available at: http://www.osumcradiology. org/resources/High-Yield-Rad-info/Rectal-MRI.pdf (accessed August 12, 2018). (In Russian).Moran M.R., James E.C., Rothenberger D.A., Goldberg S.M. Prognostic value of positive lymph-nodes in rectal-cancer. Dis. Colon. Rectum. 1992; 35 (6): 579–581.Moran M.R., James E.C., Rothenberger D.A., Goldberg S.M. Prognostic value of positive lymph-nodes in rectal-cancer. Dis. Colon. Rectum. 1992; 35 (6): 579–581.Quirke P., Williams G. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists, 2000.Quirke P., Williams G. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists, 2000.Bipat S., Glas A.S., Slors F.J.M., Zwinderman A.H., Bossuyt P.M.M., Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – A meta-analysis. Radiology. 2004; 232 (3): 773–783. http://doi.org/10.1148/radiol.2323031368.Bipat S., Glas A.S., Slors F.J.M., Zwinderman A.H., Bossuyt P.M.M., Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – A meta-analysis. Radiology. 2004; 232 (3): 773–783. http://doi.org/10.1148/radiol.2323031368.Schnall M.D., Furth P.E.E., Rosato E.F., Kressel H.Y. Rectal tumor stage – correlation of endorectal MR-imaging and pathological findings. Radiology. 1994; 190 (3): 709–714. http://doi.org/10.1148/radiology.190.3.8115616.Schnall M.D., Furth P.E.E., Rosato E.F., Kressel H.Y. Rectal tumor stage – correlation of endorectal MR-imaging and pathological findings. Radiology. 1994; 190 (3): 709–714. http://doi.org/10.1148/radiology.190.3.8115616.Brown G., Richards C.J., Bourne M.W., Newcombe R.G., Radcliffe A.G., Dallimore N.S., Williams G.T. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histo pathologic comparison. Radiology. 2003; 227 (2): 371–377. http://doi.org/10.1148/radiol.2272011747.Brown G., Richards C.J., Bourne M.W., Newcombe R.G., Radcliffe A.G., Dallimore N.S., Williams G.T. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histo pathologic comparison. Radiology. 2003; 227 (2): 371–377. http://doi.org/10.1148/radiol.2272011747.Kotanagi H., Fukuoka T., Shibata Y., Yoshioka T., Aizawa O., Saito Y., Tur G.E., Koyama K. The size of regional lymphnodes does not correlate with the presence or absence of metastasis in lymph-nodes in rectal-cancer. J. Surg. Oncol. 1993; 54 (4): 252–254.Kotanagi H., Fukuoka T., Shibata Y., Yoshioka T., Aizawa O., Saito Y., Tur G.E., Koyama K. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph-nodes in rectal-cancer. J. Surg. Oncol. 1993; 54 (4): 252–254.Markl B., Rossle J., Arnholdt H.M., Schaller T., Krammer I., Cacchi C., Jahnig H., Schenkirsch G., Spatz H., Anthuber M. The clinical significance of lymph node size in colon cancer. Mod. Pathol. 2012; 25 (10): 1413–1422. http://doi.org/10.1038/modpathol.2012.92.Markl B., Rossle J., Arnholdt H.M., Schaller T., Krammer I., Cacchi C., Jahnig H., Schenkirsch G., Spatz H., Anthuber M. The clinical significance of lymph node size in colon cancer. Mod. Pathol. 2012; 25 (10): 1413–1422. http://doi.org/10.1038/modpathol.2012.92.Smith N.J., Shihab O., Arnaout A., Swift R.I., Brown G. MRI for detection of extramural vascular invasion in rectal cancer. Am. J. Roentgenol. 2008; 191 (5): 1517–1522. http://doi.org/10.2214/AJR.08.1298.Smith N.J., Shihab O., Arnaout A., Swift R.I., Brown G. MRI for detection of extramural vascular invasion in rectal cancer. Am. J. Roentgenol. 2008; 191 (5): 1517–1522. http://doi.org/10.2214/AJR.08.1298.Chand M., Swift R.I., Tekkis P.P., Chau I., Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br. J. Cancer. 2014; 110 (1): 19–25. http://doi.org/10.1038/bjc.2013.603.Chand M., Swift R.I., Tekkis P.P., Chau I., Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br. J. Cancer. 2014; 110 (1): 19–25. http://doi.org/10.1038/bjc.2013.603.Chand M., Evans J., Swift R.I., Tekkis P.P., West N.P., Stamp G., Heald R.J., Brown G. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann. Surg. 2015; 261 (3): 473–479. http://doi.org/10.1097/SLA.0000000000000848.Chand M., Evans J., Swift R.I., Tekkis P.P., West N.P., Stamp G., Heald R.J., Brown G. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann. Surg. 2015; 261 (3): 473–479. http://doi.org/10.1097/SLA.0000000000000848.Faes S., Gie O., Demartines N., Hahnloser D. Multidisciplinary treatment of locally advanced rectal cancer. Rev. Med. Suisse. 2016; 12 (523): 1185–1189. (In French)Faes S., Gie O., Demartines N., Hahnloser D. Multidisciplinary treatment of locally advanced rectal cancer. Rev. Med. Suisse. 2016; 12 (523): 1185–1189. (In French) 47. Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. The Lancet. 1908; 172 (4451): 1812–1813.Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. The Lancet. 1908; 172 (4451): 1812–1813.Heald R.J. The holy plane of rectal surgery. J. R. Soc. Med. 1988; 81 (9): 503–508. PMID: 3184105. 49. Heald R.J., Moran B.J., Ryall R.D.H., Sexton R., MacFarlane J.K. Rectal cancer – the basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133 (8): 894–898.Heald R.J. The holy plane of rectal surgery. J. R. Soc. Med. 1988; 81 (9): 503–508. PMID: 3184105.Quirke P., Dixon M.F., Durdey P., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection – histopathological study of lateral tumor spread and surgical excision. Lancet. 1986; 2 (8514): 996–999.Heald R.J., Moran B.J., Ryall R.D.H., Sexton R., MacFarlane J.K. Rectal cancer – the basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133 (8): 894–898.Taylor F.G.M., Quirke P., Heald R.J., Moran B.J., Blomqvist L., Swift I.R., Sebag-Montefiore D., Tekkis P., Brown G. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year followup results of the MERCURY study. J. Clin. Oncol. 2014; 32 (1): 34–114. http://doi.org/10.1200/JCO.2012.45.3258.Quirke P., Dixon M.F., Durdey P., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection – histopathological study of lateral tumor spread and surgical excision. Lancet. 1986; 2 (8514): 996–999.Bown E.J., Lloyd G.M., Boyle KM., Miller A.S. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int. J. Colorectal. Dis. 2014; 29 (2): 147–155. http://doi.org/10.1007/s00384-013-1772-z.Taylor F.G.M., Quirke P., Heald R.J., Moran B.J., Blomqvist L., Swift I.R., Sebag-Montefiore D., Tekkis P., Brown G. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year followup results of the MERCURY study. J. Clin. Oncol. 2014; 32 (1): 34–114. http://doi.org/10.1200/JCO.2012.45.3258.Zhao J., Du C.Z., Sun Y.S., Gu J. Patterns and prognosis of locally recurrent rectal cancer following multi disciplinary treatment. Wld J. Gastroenterol. 2012; 18 (47): 7015–7020. http://doi.org/10.3748/wjg.v18.i47.7015.Bown E.J., Lloyd G.M., Boyle KM., Miller A.S. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int. J. Colorectal. Dis. 2014; 29 (2): 147–155. http://doi.org/10.1007/s00384-013-1772-z.Purkayastha S., Tekkis P.P., Athanasiou T., Tilney H.S., Darzi A.W., Heriot A.G. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9 (5): 402–411. http://doi.org/10.1111/j.1463-1318.2006.01104.x.Zhao J., Du C.Z., Sun Y.S., Gu J. Patterns and prognosis of locally recurrent rectal cancer following multi disciplinary treatment. Wld J. Gastroenterol. 2012; 18 (47): 7015–7020. http://doi.org/10.3748/wjg.v18.i47.7015.Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., St Rose S., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br. J. Surg. 2011; 98 (6): 872–879. DOI: 10.1002/bjs.7458.Purkayastha S., Tekkis P.P., Athanasiou T., Tilney H.S., Darzi A.W., Heriot A.G. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9 (5): 402–411. http://doi.org/10.1111/j.1463-1318.2006.01104.x.Rullier E., Denost Q., Vendrely V., Rullier A., Laurent C. Low rectal cancer: classification and standardization of surgery. Dis. Colon. Rectum. 2013; 56 (5): 560–567. http://doi.org/10.1097/DCR.0b013e31827c4a8c.Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., St Rose S., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br. J. Surg. 2011; 98 (6): 872–879. DOI: 10.1002/bjs.7458.Perez R., Habr-Gama A., Camargo A., Souza S., Parmigiani R., Galante P., Salim A., Souza J., Quevedo B., Felicio N., Gama-Rodrigues J. Prediction of response to neoadjuvant chemoradiation therapy in patients with distal rectal cancer by gene expression using last generation sequencing. Dis. Colon. Rectum. 2011; 54 (5): Е7–E7.Rullier E., Denost Q., Vendrely V., Rullier A., Laurent C. Low rectal cancer: classification and standardization of surgery. Dis. Colon. Rectum. 2013; 56 (5): 560–567. http://doi.org/10.1097/DCR.0b013e31827c4a8c.Chernikovskii I.L. Multidisciplinary approach in the diagnosis and treatment of resectable rectal cancer. Practical oncology. 2015; 16 (2): 69–76. (In Russian)Perez R., Habr-Gama A., Camargo A., Souza S., Parmigiani R., Galante P., Salim A., Souza J., Quevedo B., Felicio N., Gama-Rodrigues J. Prediction of response to neoadjuvant chemoradiation therapy in patients with distal rectal cancer by gene expression using last generation sequencing. Dis. Colon. Rectum. 2011; 54 (5): Е7–E7.Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl. J. Med. 2004; 351 (17): 1731–1740. http://doi.org/10.1056/NEJMoa040694.Черниковский И.Л. Мультидисциплинарный подход в диагностике и лечении резектабельного рака прямой кишки. Практическая онкология. 2015; 16 (2): 69–76.Hotker A.M., Tarlinton L., Mazaheri Y., Woo K.M., Gonen M., Saltz L.B., Goodman K.A., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemo radiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Eur. Radiol. 2016; 26 (12): 4303–4312. http://doi.org/10.1007/s00330-016-4283-9.Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl. J. Med. 2004; 351 (17): 1731–1740. http://doi.org/10.1056/NEJMoa040694.Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12 (1): 19–23.Hotker A.M., Tarlinton L., Mazaheri Y., Woo K.M., Gonen M., Saltz L.B., Goodman K.A., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemo radiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Eur. Radiol. 2016; 26 (12): 4303–4312. http://doi.org/10.1007/s00330-016-4283-9.Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer – a meta-analysis. J. Am. Med. Ass. 2000; 284 (8): 1008–1015.Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12 (1): 19–23.Bhangu A., Ali S.M., Cunningham D., Brown G., Tekkis P. Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis. 2013; 15 (2): 156–163. http://doi.org/10.1111/j.1463-1318.2012.03123.x.Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer – a meta-analysis. J. Am. Med. Ass. 2000; 284 (8): 1008–1015.Tyuryaeva E.I. Chemoradiotherapy for rectal cancer. Practical oncology. 2008; 9 (1): 31–38. (In Russian)Bhangu A., Ali S.M., Cunningham D., Brown G., Tekkis P. Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis. 2013; 15 (2): 156–163. http://doi.org/10.1111/j.1463-1318.2012.03123.x.Keam S.J., Dunn C.J., Figgitt D.P. Oxaliplatin – in operable colorectal cancer. Drugs. 2005; 65 (1): 89–96. http://doi.org/10.2165/00003495-200565010-00005.Тюряева Е.И. Химиолучевое лечение рака прямой кишки. Практическая онкология. 2008; 9 (1): 31–38.Hoetker A.M., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review. Dis. Colon Rectum. 2014; 57 (6): 790–799. http://doi.org/10.1097/DCR.0000000000000127.Keam S.J., Dunn C.J., Figgitt D.P. Oxaliplatin – in operable colorectal cancer. Drugs. 2005; 65 (1): 89–96. http://doi.org/10.2165/00003495-200565010-00005.Evans J., Tait D., Swift I., Pennert K., Tekkis P., Wotherspoon A., Chau I., Cunningham D., Brown G. Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis. Colon Rectum. 2011; 54 (10): 1251–1259. http://doi.org/10.1097/DCR.0b013e3182281f4b.Hoetker A.M., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review. Dis. Colon Rectum. 2014; 57 (6): 790–799. http://doi.org/10.1097/DCR.0000000000000127.Patel U.B., Brown G., Rutten H., West N., SebagMontefiore D., Glynne-Jones R., Rullier E., Peeters M., Van Cutsem E., Ricci S., Van de Velde C., Kjell P., Quirke P. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann. Surg. Oncol. 2012; 19 (9): 2842–2852. http://doi.org/10.1245/s10434-012-2309-3.Evans J., Tait D., Swift I., Pennert K., Tekkis P., Wotherspoon A., Chau I., Cunningham D., Brown G. Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis. Colon Rectum. 2011; 54 (10): 1251–1259. http://doi.org/10.1097/DCR.0b013e3182281f4b.Patel U.B., Brown G. MRI-based assessment of tumor regression in rectal cancer. Curr. Colorectal Cancer Rep. 2013; 9 (2): 136–145. http://doi.org/10.1007/s11888-013-0169-2.Patel U.B., Brown G., Rutten H., West N., SebagMontefiore D., Glynne-Jones R., Rullier E., Peeters M., Van Cutsem E., Ricci S., Van de Velde C., Kjell P., Quirke P. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann. Surg. Oncol. 2012; 19 (9): 2842–2852. http://doi.org/10.1245/s10434-012-2309-3.Sassen S., de Booij M., Sosef M., Berendsen R., Lammering G., Clarijs R., Bakker M., Beets-Tan R., Warmerdam F., Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 2013; 23 (12): 3440–3449. http://doi.org/10.1007/s00330-013-2956-1.Patel U.B., Brown G. MRI-based assessment of tumor regression in rectal cancer. Curr. Colorectal Cancer Rep. 2013; 9 (2): 136–145. http://doi.org/10.1007/s11888-013-0169-2.Park M.J., Kim S.H., Lee S.J., Jang K.M., Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011; 260 (3): 771–780. http://doi.org/10.1148/radiol.11102135.Sassen S., de Booij M., Sosef M., Berendsen R., Lammering G., Clarijs R., Bakker M., Beets-Tan R., Warmerdam F., Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 2013; 23 (12): 3440–3449. http://doi.org/10.1007/s00330-013-2956-1.Boone D., Taylor S.A., Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis. 2013; 15 (6): 655–661. http://doi.org/10.1111/codi.12241.Park M.J., Kim S.H., Lee S.J., Jang K.M., Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011; 260 (3): 771–780. http://doi.org/10.1148/radiol.11102135.Heijnen L.A., Lambregts D.M.J., Mondal D., Martens M.H., Riedl R.G., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur. Radiol. 2013; 23 (12): 3354–3360. http://doi.org/10.1007/s00330-013-2952-5.Boone D., Taylor S.A., Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis. 2013; 15 (6): 655–661. http://doi.org/10.1111/codi.12241.Alberda W.J., Dassen H.P.N., Dwarkasing R.S., Willemssen F.E.J.A., van der Pool A.E.M., de Wilt J.H.W., Burger J.W. A., Verhoef C. Prediction of tumor stage and lymph node involvement with dynamic contrastenhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis. 2013; 28 (4): 573–580. http://doi.org/10.1007/s00384-012-1576-6.Heijnen L.A., Lambregts D.M.J., Mondal D., Martens M.H., Riedl R.G., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur. Radiol. 2013; 23 (12): 3354–3360. http://doi.org/10.1007/s00330-013-2952-5.Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J. Clin. Oncol. 2006; 24 (20): 3293–3298. http://doi.org/10.1200/JCO.2006.06.8080.Alberda W.J., Dassen H.P.N., Dwarkasing R.S., Willemssen F.E.J.A., van der Pool A.E.M., de Wilt J.H.W., Burger J.W. A., Verhoef C. Prediction of tumor stage and lymph node involvement with dynamic contrastenhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis. 2013; 28 (4): 573–580. http://doi.org/10.1007/s00384-012-1576-6.Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Rectal Cancer. Rectal Cancer-A Multidisciplinary Approach to Management / Giulio D., Santoro A. InTech. 2011; 75–98.Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J. Clin. Oncol. 2006; 24 (20): 3293–3298. http://doi.org/10.1200/JCO.2006.06.8080.Arya S., Das D., Engineer R., Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J. Radiol. Imaging. 2015; 25 (2): 148–161. http://doi.org/10.4103/0971-3026.155865.Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Rectal Cancer. Rectal Cancer-A Multidisciplinary Approach to Management / Giulio D., Santoro A. InTech. 2011; 75–98.Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Rectal Cancer. Rectal Cancer-A Multidisciplinary Approach to Management / Giulio D., Santoro A. InTech. 2011; 75–98.Arya S., Das D., Engineer R., Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J. Radiol. Imaging. 2015; 25 (2): 148–161. http://doi.org/10.4103/0971-3026.155865.Arya S., Das D., Engineer R., Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J. Radiol. Imaging. 2015; 25 (2): 148–161. http://doi.org/10.4103/0971-3026.155865.

The authors declare that there are no conflicts of interest present.